Literature DB >> 11176809

Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy.

C M Rutter1, M T Mandelson, M B Laya, D J Seger, S Taplin.   

Abstract

CONTEXT: Initiation of hormone replacement therapy (HRT) has been shown to increase breast density. Evidence exists that increased breast density decreases mammographic sensitivity. The effects on breast density of discontinuing and continuing HRT have not been studied systematically.
OBJECTIVE: To examine the effects of initiation, discontinuation, and continued use of HRT on breast density in postmenopausal women. DESIGN, SETTING, AND PARTICIPANTS: Observational cohort study of 5212 naturally postmenopausal women aged 40 to 96 years and enrolled in a large health maintenance organization in western Washington State who had 2 screening mammograms between 1996 and 1998. MAIN OUTCOME MEASURES: Breast density, assessed using the clinical radiologists' BI-RADS 4-point scale, compared among women who did not use HRT before either mammogram (nonusers); who used HRT before the first but not before the second mammogram (discontinuers); who used HRT before the second but not before the first mammogram (initiators); and who used HRT prior to both mammograms (continuing users).
RESULTS: Relative to nonusers, women who initiated HRT were more likely to show increases in breast density (relative risk [RR], 2.57; 95% confidence interval [CI], 2.12-3.08), while women who discontinued HRT use were more likely to show decreases in density (RR, 1.81; 95% CI, 1.06-2.98) and women who continued to use HRT were more likely to show both increases in density (RR, 1.33; 95% CI, 1.13-1.55) and sustained high density (RR, 1.45; 95% CI, 1.33-1.58).
CONCLUSIONS: These results indicate that breast density changes associated with HRT are dynamic, increasing with initiation, and decreasing with discontinuation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11176809     DOI: 10.1001/jama.285.2.171

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  80 in total

Review 1.  Mammographic densities as a marker of human breast cancer risk and their use in chemoprevention.

Authors:  N F Boyd; L J Martin; J Stone; C Greenberg; S Minkin; M J Yaffe
Journal:  Curr Oncol Rep       Date:  2001-07       Impact factor: 5.075

Review 2.  Clinical and epidemiological issues in mammographic density.

Authors:  Valentina Assi; Jane Warwick; Jack Cuzick; Stephen W Duffy
Journal:  Nat Rev Clin Oncol       Date:  2011-12-06       Impact factor: 66.675

3.  Segmentation of the fibro-glandular disc in mammograms using Gaussian mixture modelling.

Authors:  R J Ferrari; R M Rangayyan; R A Borges; A F Frère
Journal:  Med Biol Eng Comput       Date:  2004-05       Impact factor: 2.602

Review 4.  Breast tissue composition and susceptibility to breast cancer.

Authors:  Norman F Boyd; Lisa J Martin; Michael Bronskill; Martin J Yaffe; Neb Duric; Salomon Minkin
Journal:  J Natl Cancer Inst       Date:  2010-07-08       Impact factor: 13.506

5.  Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use.

Authors:  Karla Kerlikowske; Andrea J Cook; Diana S M Buist; Steve R Cummings; Celine Vachon; Pamela Vacek; Diana L Miglioretti
Journal:  J Clin Oncol       Date:  2010-07-19       Impact factor: 44.544

6.  Mammographic Density and Circulating Sex Hormones: a Cross-Sectional Study in Postmenopausal Korean Women.

Authors:  Kayoung Lee; Jung Eun Yoo; Tuong Linh Nguyen; John Llewelyn Hopper; Yun-Mi Song
Journal:  Horm Cancer       Date:  2018-07-24       Impact factor: 3.869

Review 7.  Postmenopausal hormone replacement therapy: effects on normal mammary gland in humans and in a mouse postmenopausal model.

Authors:  Sandra Z Haslam; Janet R Osuch; A M Raafat; L J Hofseth
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-01       Impact factor: 2.673

8.  Body mass index, tumor characteristics, and prognosis following diagnosis of early-stage breast cancer in a mammographically screened population.

Authors:  Aruna Kamineni; Melissa L Anderson; Emily White; Stephen H Taplin; Peggy Porter; Rachel Ballard-Barbash; Kathleen Malone; Diana S M Buist
Journal:  Cancer Causes Control       Date:  2012-12-07       Impact factor: 2.506

9.  Fertility drug use and mammographic breast density in a mammography screening cohort of premenopausal women.

Authors:  Brian L Sprague; Amy Trentham-Dietz; Mary Beth Terry; Hazel B Nichols; Andrew J Bersch; Diana S M Buist
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

10.  Conjugated equine estrogen influence on mammographic density in postmenopausal women in a substudy of the women's health initiative randomized trial.

Authors:  Anne McTiernan; Rowan T Chlebowski; Christopher Martin; Jennifer David Peck; Aaron Aragaki; Etta D Pisano; C Y Wang; Karen C Johnson; Joann E Manson; Robert B Wallace; Mara Z Vitolins; Gerardo Heiss
Journal:  J Clin Oncol       Date:  2009-11-09       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.